The news from psychedelia is starting to trickle (thank god!) as we head into year’s end and approach 2023, a pivotal year for psychedelic policy and…
5
Plus updates from Beckley PsyTech and Tactogen
2
Today we’re looking at the recent psychedelic-related election results from Colorado and Oregon. Voters in Colorado approved Prop 122, which…
2
This week we’re looking at: Beckley Psytech’s acquisition of Eleusis Therapeutics The potential for naturalistic research in Colorado Psychedelic…
2
Greetings and salutations. Welcome to this week’s dispatch! My therapist tasked me with finding a habit that would push me out of my comfort zone and…
1
Greetings from NYC! I have just arrived for the Horizons Conference and looking forward to seeing many of you this weekend! Today’s dispatch is brief…
3
Happy Friday to those who celebrate. For those with young children, happy Monday. In today’s dispatch, we’re taking a look at the following: Alberta’s…
6
And other related Ketamine news
3
Today we are looking at A Review of a paper on Psychedelic-Induced Neuroplasticity A look ahead at the inaugural The Trip Report Live, a panel…
5
With the Leadership team from the policy and advocacy group, Reason for Hope
2
6
Today we’re focusing on two developments at the intersection of access and research: First up, Sunstone Therapies, a clinic and research center focused…
5
1
In any given week, some development in the psychedelic space—a scientific study, a company announcement, or policy development—will completely take over…
4
1